Department of Primary Care and Public Health, Imperial College London, London W6 8RP, UK.
BMJ. 2012 Aug 30;345:e5567. doi: 10.1136/bmj.e5567.
To examine the effect of systolic and diastolic blood pressure achieved in the first year of treatment on all cause mortality in patients newly diagnosed with type 2 diabetes, with and without established cardiovascular disease.
Retrospective cohort study.
United Kingdom General Practice Research Database, between 1990 and 2005.
126,092 adult patients (age ≥ 18 years) with a new diagnosis of type 2 diabetes who had been registered with participating practices for at least 12 months.
All cause mortality.
Before diagnosis, 12,379 (9.8%) patients had established cardiovascular disease (myocardial infarction or stroke). During a median follow-up of 3.5 years, we recorded 25,495 (20.2%) deaths. In people with cardiovascular disease, tight control of systolic (<130 mm Hg) and diastolic (<80 mm Hg) blood pressure was not associated with improved survival, after adjustment for baseline characteristics (age at diagnosis, sex, practice level clustering, deprivation score, body mass index, smoking, HbA(1c) and cholesterol levels, and blood pressure). Low blood pressure was also associated with an increased risk of all cause mortality. Compared with patients who received usual control of systolic blood pressure (130-139 mm Hg), the hazard ratio of all cause mortality was 2.79 (95% confidence interval 1.74 to 4.48, P<0.001) for systolic blood pressure at 110 mm Hg. Compared with patients who received usual control of diastolic blood pressure (80-84 mm Hg), the hazard ratios were 1.32 (1.02 to 1.78, P=0.04) and 1.89 (1.40 to 2.56, P<0.001) for diastolic blood pressures at 70-74 mm Hg and lower than 70 mm Hg, respectively. Similar associations were found in people without cardiovascular disease. Subgroup analyses of people diagnosed with hypertension and who received treatment for hypertension confirmed initial findings.
Blood pressure below 130/80 mm Hg was not associated with reduced risk of all cause mortality in patients with newly diagnosed diabetes, with or without known cardiovascular disease. Low blood pressure, particularly below 110/75 mm Hg, was associated with an increased risk for poor outcomes.
研究新诊断为 2 型糖尿病的患者在治疗的第一年中收缩压和舒张压的控制水平对无或有已确诊心血管疾病的患者全因死亡率的影响。
回顾性队列研究。
1990 年至 2005 年期间,英国普通实践研究数据库。
126092 名年龄≥18 岁的新诊断为 2 型糖尿病且在参与研究的诊所登记至少 12 个月的成年患者。
全因死亡率。
在诊断前,12379 例(9.8%)患者患有已确诊的心血管疾病(心肌梗死或中风)。在中位随访 3.5 年期间,我们记录了 25495 例(20.2%)死亡。在患有心血管疾病的人群中,在调整了基线特征(诊断时的年龄、性别、诊所分级、贫困评分、体重指数、吸烟、糖化血红蛋白和胆固醇水平以及血压)后,收缩压(<130mmHg)和舒张压(<80mmHg)的严格控制与生存率的提高无关。较低的血压也与全因死亡率的增加风险相关。与接受常规收缩压控制(130-139mmHg)的患者相比,收缩压为 110mmHg 的患者的全因死亡率的危险比为 2.79(95%置信区间为 1.74 至 4.48,P<0.001)。与接受常规舒张压控制(80-84mmHg)的患者相比,舒张压分别为 70-74mmHg 和<70mmHg 的患者的危险比分别为 1.32(1.02 至 1.78,P=0.04)和 1.89(1.40 至 2.56,P<0.001)。在没有心血管疾病的人群中也发现了类似的关联。对诊断为高血压并接受高血压治疗的患者的亚组分析证实了最初的发现。
在新诊断为糖尿病的患者中,血压低于 130/80mmHg 与全因死亡率的降低无关,无论是否存在已知的心血管疾病。低血压,尤其是低于 110/75mmHg,与不良结局的风险增加相关。